Unbiased Analysis of Today's Healthcare Issues

Archive for the 'My Papers' Category

Presentation at 2017 British Society for Rheumatology

For those attending the British Society for Rheumatology Annual Meeting in Birmingham, England, I will be giving a podium presentation on Wednesday, April 26 at 12pm BST titled “Economic Burden of Rheumatoid Arthritis is Higher for Anti-Citrullinated Protein Antibody-Positive Patients.”  Come by Hall 6 to check it out along with other presentations in the Clinical and […]

Read the rest of this entry »

JMCP Award for Excellence

This week at the 2017 Academy of Managed Care Pharmacy (AMCP) conference, the Journal of Managed Care & Specialty Pharmacy (JMCP) announced its annual Award for Excellence. The award was established in 2002 “…to recognize an article that represents the best scholarly work in managed care pharmacy.” This year, the 2016 Award for Excellence went to […]

Read the rest of this entry »

Special Issue on Value Assessment Frameworks

Value in Health has a Special Issue on Value Assessment Frameworks.   The issue includes one of my papers (co-authored with Taylor T. Schwartz, Tony Okoro, John A. Romley) titled Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments.  The abstract is below.   Background: Previous research indicates that patients value therapies that provide […]

Read the rest of this entry »

Figuring out how to measure value

Unlike some other organizations, [the Innovation and Value Initiative (IVI)] is not interested in a top-down, bureaucratic process for setting prices or measuring value, says Shafrin. Rather, IVI aims to disseminate best practices for measuring value and reimbursing treatments based on this value. “We are looking at balancing innovation and value,” he says. “Some people are […]

Read the rest of this entry »

Advancing Value in Healthcare

Rapid biomedical progress and rising healthcare costs have led to increasing calls to link spending to value rather than volume of care in the United States. These calls have come from payers, patients, providers, and even innovators. For example, Medicare aims to link 90% of payments to some form of value-based reimbursement. Providers-based organizations such […]

Read the rest of this entry »

Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis

This is the title of my latest article in JMCP co-authored with Arijit Ganguli,  Yuri Sanchez Gonzalez, Jin Joo Shim, and Seth A. Seabury.  The paper’s abstract is below. BACKGROUND: There is considerable push to improve value in health care by simultaneously increasing quality while lowering or containing costs. However, for diseases that are best […]

Read the rest of this entry »

Precision medicine will increase drug prices and that’s a good thing

Check out my latest article at MedCity News looking at how the advent of precision medicine will affect patients, regulators and payers. The article describes how precision medicine will be good for patients.  Precision medicines will likely be more expensive that regular therapies, but–because they are targeted to more specific populations–aggregate spending on pharmaceuticals could increase […]

Read the rest of this entry »

Patterns of Adherence to Atypical Antipsychotics

A study titled “Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Joanna P. MacEwan, Felicia M. Forma, Jason Shafrin, Ainslie Hatch, Darius N. Lakdawalla, Jean-Pierre Lindenmayer. The abstract is below.  Go check it out! BACKGROUND: Poor medication adherence […]

Read the rest of this entry »

The Healthcare Economist on NPR

Check out my interview on NPR with Here & Now’s Jeremy Hobson about what recent changes in health insurance premiums changes mean for the future of the Affordable Care Act.  

Read the rest of this entry »

The value of adherence information

A study titled “Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Taylor T. Schwartz, Darius N. Lakdawalla, and Felicia M. Forma.  The abstract is below.  Go check it out!   […]

Read the rest of this entry »